Antonio Ciaccio

789 total citations
18 papers, 194 citations indexed

About

Antonio Ciaccio is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Antonio Ciaccio has authored 18 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 11 papers in Epidemiology and 3 papers in Oncology. Recurrent topics in Antonio Ciaccio's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (10 papers) and Liver Disease and Transplantation (4 papers). Antonio Ciaccio is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (10 papers) and Liver Disease and Transplantation (4 papers). Antonio Ciaccio collaborates with scholars based in Italy, United States and Austria. Antonio Ciaccio's co-authors include Pietro Invernizzi, Sara Massironi, Miki Scaravaglio, Laura Cristoferi, Diego Cortinovis, Paolo Angelo Cortesi, Raffaella Longarini, LG Mantovani, Roberta Rossi and Alessandra Elvevi and has published in prestigious journals such as Journal of Hepatology, American Journal of Transplantation and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Antonio Ciaccio

16 papers receiving 192 citations

Peers

Antonio Ciaccio

HEPAT

EPIDE

SURGE

ONCOL

PRM

Erica Nicola Lynch Italy

Martina Milana Italy

Sam Li‐Sheng Chen Taiwan

Axel Hsu Hong Kong

Polychronis Kemos United Kingdom

Clifford Akateh United States

Judy A. Trieu United States

Shinichi Ikeya Japan

Nico Buettner Germany

Joren R. ten Hove Netherlands

Erica Nicola Lynch Italy

Antonio Ciaccio

103 ×1.3

HEPAT

132 ×1.7

EPIDE

47 ×0.6

SURGE

29 ×0.5

ONCOL

15 ×0.4

PRM

Citations per year, relative to Antonio Ciaccio Antonio Ciaccio (= 1×) peers Erica Nicola Lynch

Countries citing papers authored by Antonio Ciaccio

Since Specialization

Citations

This map shows the geographic impact of Antonio Ciaccio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Ciaccio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Ciaccio more than expected).

Fields of papers citing papers by Antonio Ciaccio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Ciaccio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Ciaccio. The network helps show where Antonio Ciaccio may publish in the future.

Co-authorship network of co-authors of Antonio Ciaccio

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Ciaccio. A scholar is included among the top collaborators of Antonio Ciaccio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Ciaccio. Antonio Ciaccio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Maino, Cesare, Antonio Ciaccio, Mattia Garancini, et al.. (2024). Functional liver imaging score (FLIS) can predict adverse events in HCC patients. European Journal of Radiology. 180. 111695–111695.

Cazzaniga, Marina Elena, Antonio Ciaccio, Romano Danesi, et al.. (2023). Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project. Frontiers in Oncology. 13. 1247270–1247270. 5 indexed citations

Elvevi, Alessandra, Miki Scaravaglio, Roberta Rossi, et al.. (2022). Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Annals of Hepatology. 27(5). 100737–100737. 84 indexed citations

Ciardullo, Stefano, Alessandro Mantovani, Antonio Ciaccio, et al.. (2022). Hepatitis C virus infection and diabetes: A complex bidirectional relationship. Diabetes Research and Clinical Practice. 187. 109870–109870. 8 indexed citations

Ciaccio, Antonio, Alessandra Elvevi, Camilla Gallo, et al.. (2022). Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology. 35(3). 241–247. 6 indexed citations

Massironi, Sara, Lorena Pirola, Giacomo Mulinacci, et al.. (2022). Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks. Inflammatory Bowel Diseases. 29(9). 1477–1487. 2 indexed citations

Scaravaglio, Miki, Antonio Ciaccio, Martina De Luca, et al.. (2022). Liver toxicity associated to novel cyclin-dependent kinase inhibitor ribociclib in a cohort of advanced breast cancer patients. Journal of Hepatology. 77. S404–S405. 1 indexed citations

Cortesi, Paolo Angelo, Sara Conti, L Scalone, et al.. (2020). Health related quality of life in chronic liver diseases. Liver International. 40(11). 2630–2642. 22 indexed citations

Cortesi, Paolo Angelo, et al.. (2019). Systematic review: economic evaluations of HCV screening in the direct‐acting antivirals era. Alimentary Pharmacology & Therapeutics. 49(9). 1126–1133. 10 indexed citations

10.

Strazzabosco, Mario, Paolo Angelo Cortesi, Sara Conti, et al.. (2019). Clinical outcome indicators in chronic hepatitis B and C: A primer for value‐based medicine in hepatology. Liver International. 40(1). 60–73. 4 indexed citations

11.

Carbone, Marco, Laura Cristoferi, Paolo Angelo Cortesi, et al.. (2017). Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(4). 1415–1422. 3 indexed citations

12.

Ciaccio, Antonio, Paolo Angelo Cortesi, Giuseppe Bellelli, et al.. (2016). Direct‐acting antivirals combination for elderly patients with chronic hepatitis C: A cost‐effectiveness analysis. Liver International. 37(7). 982–994. 15 indexed citations

13.

Cortesi, Paolo Angelo, LG Mantovani, Antonio Ciaccio, et al.. (2015). Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis. American Journal of Transplantation. 15(7). 1817–1826. 15 indexed citations

14.

Ciaccio, Antonio, Paolo Angelo Cortesi, Giuseppe Bellelli, et al.. (2015). Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis. Digestive and Liver Disease. 47. e15–e16. 1 indexed citations

15.

Cortesi, Paolo Angelo, LG Mantovani, Antonio Ciaccio, et al.. (2014). The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation. Value in Health. 17(7). A367–A368. 1 indexed citations

16.

Cortesi, Paolo Angelo, Antonio Ciaccio, Matteo Rota, et al.. (2014). Management of treatment‐naïve chronic hepatitisCgenotype 1 patients: a cost‐effectiveness analysis of treatment options. Journal of Viral Hepatitis. 22(2). 175–183. 15 indexed citations

17.

Cortesi, Paolo Angelo, Antonio Ciaccio, Matteo Rota, et al.. (2014). Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis. Digestive and Liver Disease. 46. e11–e11. 2 indexed citations

18.

Cortesi, Paolo Angelo, Antonio Ciaccio, Matteo Rota, et al.. (2014). P1215 MANAGEMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 TREATMENT-NAIVE PATIENTS IN AN ERA OF RISING OPPORTUNITIES AND COSTS – A COST-EFFECTIVENESS ANALYSIS OF TREATMENT OPTIONS. Journal of Hepatology. 60(1). S493–S493.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact